661 related articles for article (PubMed ID: 20077378)
41. The pitfalls of misreading: what does "industry funding of medical education" actually say?
Spielman B
Am J Bioeth; 2010 Jan; 10(1):24-5. PubMed ID: 20077332
[No Abstract] [Full Text] [Related]
42. Radiology and industry: can this relationship be saved?
Forman HP
J Am Coll Radiol; 2006 May; 3(5):333-4. PubMed ID: 17412076
[No Abstract] [Full Text] [Related]
43. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
Hodges B
CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
[TBL] [Abstract][Full Text] [Related]
44. The AAMC exhibits the behavior it condemns.
Stossel TP
Am J Bioeth; 2010 Jan; 10(1):26-7. PubMed ID: 20077333
[No Abstract] [Full Text] [Related]
45. The pitfalls of deducing ethics from behavioral economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing.
Huddle TS
Am J Bioeth; 2010 Jan; 10(1):1-8. PubMed ID: 20077321
[TBL] [Abstract][Full Text] [Related]
46. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
Rutledge P; Crookes D; McKinstry B; Maxwell SR
Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
[TBL] [Abstract][Full Text] [Related]
47. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
Brett AS; Burr W; Moloo J
Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
[TBL] [Abstract][Full Text] [Related]
48. Dangerous liaisons: doctors-in-training and the pharmaceutical industry.
Pokorny AM; Gittins CB
Intern Med J; 2015 Oct; 45(10):1085-8. PubMed ID: 26429220
[TBL] [Abstract][Full Text] [Related]
49. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia.
Wilson A
Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745
[No Abstract] [Full Text] [Related]
50. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
Morin K; Morse LJ
Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
[No Abstract] [Full Text] [Related]
51. Proposed guidelines for housestaff interaction with pharmaceutical companies.
Forrest DM; Ruedy J
Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
[TBL] [Abstract][Full Text] [Related]
52. Doctors and drug companies.
Lambert LA
N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
[No Abstract] [Full Text] [Related]
53. Attitudes of physicians and public to pharmaceutical industry 'gifts'.
Macneill PU; Kerridge IH; Newby D; Stokes BJ; Doran E; Henry DA
Intern Med J; 2010 May; 40(5):335-41. PubMed ID: 20345507
[TBL] [Abstract][Full Text] [Related]
54. [Clinical practice and pharmaceutical industry: an always difficult relationship].
Mastai R
Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851
[No Abstract] [Full Text] [Related]
55. Commentary: Addressing corporate influence through ethical guidelines.
Greenland S
Int J Epidemiol; 2008 Feb; 37(1):57-9; discussion 65-8. PubMed ID: 18245052
[No Abstract] [Full Text] [Related]
56. Use of and attitudes towards the prescribing guidelines booklet in primary health care doctors.
Axelsson MA; Spetz M; Mellén A; Wallerstedt SM
BMC Clin Pharmacol; 2008 Sep; 8():8. PubMed ID: 18808661
[TBL] [Abstract][Full Text] [Related]
57. [The influence of the pharmaceutical industry on treatment guidelines].
Smulders YM; Thijs A
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2429-31. PubMed ID: 18064860
[TBL] [Abstract][Full Text] [Related]
58. Resident and faculty perceptions of conflict of interest in medical education.
Watson PY; Khandelwal AK; Musial JL; Buckley JD
J Gen Intern Med; 2005 Apr; 20(4):357-9. PubMed ID: 15857494
[TBL] [Abstract][Full Text] [Related]
59. Drug industry is told to stop gifts to doctors.
Pear R
N Y Times Web; 2002 Oct; ():A1, A29. PubMed ID: 12474836
[No Abstract] [Full Text] [Related]
60. Relationships between medical students and drug companies in New Zealand.
Wyber R; Fancourt N; Stone B
N Z Med J; 2011 Aug; 124(1341):58-64. PubMed ID: 21959637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
